EP3536339
METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.8.2014EP published:
6.10.2021EP application number:
19162585.4
EPO information:
European Patent Register
Max expiry date:
6.8.2034
Title:
METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB
Timeline
Today
7.8.2014EP application
6.10.2021EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
WARD, ChristineAddress:
Gaithersburg, Maryland 20878, US
Name:
ROSKOS, LorinAddress:
Gaithersburg, Maryland 20878, US
Name:
WANG, BingAddress:
Gaithersburg, Maryland 20878, US
Name:
RAIBLE, DonaldAddress:
Berwyn, Pennsylvania 19312, US
Priority
Number:
201361864950 PDate:
12.8.2013Country:
US
Classification
Categories:
A61K 39/00, A61K 39/395, G01N 33/48, A61P 11/06